Compare Manhattan Associates Inc (MANH) vs NICE Ltd (NICE) Price & Performance

MANH trades at $195.23, up 2.41% in the last 24 hours, with a bullish technical outlook supported by a golden cross and strong momentum indicators. The company reported Q2 2026 EPS of $1.39, beating estimates, and maintains robust profitability with an 18.67% net income margin. However, high valuation ratios like a P/E of 56.07 and ongoing legal investigations pose concerns.

Outlook is positive with an 80% analyst buy rating and a $210.33 consensus price target, implying ~8% upside. Key risks include elevated valuation multiples and fiduciary duty investigations by Rosen Law Firm, which could impact investor confidence near-term.

NICE stock trades at $101.85, up 4.88% today, showing strong momentum after exceeding Q2 2026 earnings expectations with $2.70 EPS versus $2.63 expected. The company maintains solid fundamentals with 65.12% gross margins and 13.86% net income margin, while technical indicators show bullish momentum with key resistance at $103. Recent partnerships with RingCentral and ESG initiatives highlight strategic growth positioning.

The outlook remains positive with analyst consensus target of $115 suggesting 13% upside potential. Key risks include competitive pressures in customer engagement software and potential margin compression as revenue growth outpaces profit growth. Institutional ownership trends show mixed activity with some firms increasing positions while others trim holdings.